Morgenthaler Ventures is a premier venture capital firm, dedicated to helping entrepreneurs build valuable companies for more than 40 years. We have invested in approximately 300 companies in the life science and information technology sectors. Our passion for supporting entrepreneurship and innovation has earned us the respect of entrepreneurs and investors alike.
Representative life science companies include: Ardian, Avidia, CardioThoracic Systems, CareMedic, Elcelyx, Ensure, FoldRx, ForSight VISION2, GlobeImmune, Innovative Pulmonary Solutions, Intergrated Vascular Systems, IPC – The Hospitalist Company, Miramar Labs, Morphotek, Moximed, OncoMed, Orexigen, Promedior, Perclose, Ra Pharma, Relievant, Ribozyme Pharmaceuticals, Second Genome, SetPoint Medical, Solta Medical, Stemgent, Transcend Medical, and Threshold Pharmaceuticals.
We have offices in Menlo Park, CA, Boston, MA and Boulder, CO.